Empagliflozin improves cardiac function through the increased production of acetylcarnitine in a murine non-diabetic heart failure model

被引：0
|
作者：
Nakao, M. [1 ]
Shimizu, I. [2 ]
Yoshida, Y. [2 ]
Katsuumi, G. [1 ]
Hayashi, Y. [1 ]
Ikegami, R. [1 ]
Suda, M. [1 ]
Wakasugi, T. [1 ]
Minamino, T. [1 ]
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Grad Sch Med & Dent, Niigata, Japan
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3496
引用
收藏
页码：2109 / 2109
页数：1
相关论文
共 50 条
  • [1] Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure.
    Shiraki, Aya
    Oyama, Jun-ichi
    Shimizu, Takahiko
    Nakajima, Takayuki
    Yokota, Takashi
    Node, Koichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931
  • [2] Characterization of diabetic and non-diabetic murine cardiac function
    Larsen, TS
    Giles, W
    Belke, D
    Dani, R
    Lopaschuk, G
    Severson, DL
    CIRCULATION, 1998, 98 (17) : 258 - 258
  • [3] Cardiac and renal effects of empagliflozin in non-diabetic rats with heart failure after myocardial infarction
    Yurista, S. R.
    Sillje, H. H. W.
    Oberdorf-Maass, S. U.
    Schouten, E. M.
    Pavez-Giani, M. G.
    Heerspink, H. J. L.
    Hillebrands, J. L.
    Van Goor, H.
    De Boer, R. A.
    Westenbrink, B. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 137 - 137
  • [4] Empagliflozin improves cardiac function in rats with chronic heart failure
    Zhenzhen Wang
    Qian Liu
    Xiaofang Wang
    Pengpeng Wang
    Zhuwen Wang
    Fenglei Zhang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 1037 - 1044
  • [5] Empagliflozin improves cardiac function in rats with chronic heart failure
    Wang, Zhenzhen
    Liu, Qian
    Wang, Xiaofang
    Wang, Pengpeng
    Wang, Zhuwen
    Zhang, Fenglei
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (02) : 1037 - 1044
  • [6] Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction
    Yurista, S. R.
    Sillje, H. H. W.
    Oberdorf-Maass, S. U.
    Schouten, E. M.
    Pavez-Giani, M. G.
    Hillebrands, J. L.
    Van Goor, H.
    Van Veldhuisen, D. J.
    De Boer, R. A.
    Westenbrink, B. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 356 - 357
  • [7] Dapagliflozin ameliorates diastolic function in a non-diabetic model of heart failure
    Cappetta, D.
    Urbanek, K.
    Ciuffreda, L. P.
    Cozzolino, A.
    Coppini, R.
    Berrino, L.
    De Angelis, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S5 - S5
  • [8] Homoarginine Supplementation Improves Cardiac Function in a Murine Model of Ischaemic Heart Failure
    Atzler, Dorothee
    McAndrew, Debra J.
    Crabtree, Mark
    Hale, Ashley
    Bailey, Jade
    Cordts, Kathrin
    Schneider, Jurgen E.
    Zervou, Sevasti
    Schwedhelm, Edzard
    Neubauer, Stefan
    Lygate, Craig A.
    CIRCULATION, 2015, 132
  • [9] EMPAGLIFLOZIN REDUCES OF INORGANIC PHOSPHATE EXCRETION IN NON-DIABETIC RATS WITH CHRONIC HEART FAILURE?
    Beresneva, Olga
    Kulikov, Aleksandr
    Parastaeva, Marina
    Okovityi, Sergey
    Ivkin, Dmitry
    Zubina, Irina
    Khasun, Mokhamad
    Kayukov, Ivan
    Kucher, Anatoly
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [10] Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy
    Garcia-Ropero, Alvaro
    Santos-Gallego, Carlos G.
    Vargas-Delgado, Ariana P.
    Requena-Ibanez, Juan Antonio
    Picatoste, Belen
    Ishikawa, Kiyotake
    Sanz, Javier
    Tunon, Jose
    Badimon, Juan J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (09) : 635 - 642
12345